Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
about
Psoriasis registries worldwide: systematic overview on registry publications.Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies.Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.Measurement of disease severity in cutaneous autoimmune diseases.Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.The Prevalence of Periodontitis Is Increased in Psoriasis and Linked to Its Inverse Subtype.Drug survival rates and reasons for drug discontinuation in psoriasis.Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial."Drug-Survival"-Raten und Gründe für den Abbruch von Systemtherapien bei Psoriasis.Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm® - and placebo-controlled trial (BRIDGE).Fumaric acid esters in the management of psoriasis.
P2860
Q30251454-DE012260-C839-4A7F-B824-4CB077F25074Q34046298-66F27067-9F14-4F10-9C2A-6481EB5C3906Q36316015-B57AC2C8-03DC-482D-BDAF-24A855D19127Q40380596-AC6BA968-F673-4436-B0E5-92F8639E4036Q41558860-7092DED3-4D03-493A-80CC-84530456C226Q47318089-06371C2B-098D-4CCB-AD2C-E182FE611E5FQ47608847-DE276FC5-1E79-4354-9FDC-71EE00204A5BQ47624590-EE1B6BE6-AB60-4473-97A9-5A0C8DF9B8B5Q51126486-1735493F-8202-4D8D-BAE8-D30DF014E098Q52844749-41B3375F-8B53-494E-A725-A73C0FB4F028Q53725578-F4AA8154-EB34-4ABC-BE4A-EED08BB7EB53Q54958047-A71485D3-80A3-4998-8358-1C70F2920760
P2860
Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@ast
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@en
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@nl
type
label
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@ast
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@en
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@nl
prefLabel
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@ast
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@en
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@nl
P2093
P2860
P1476
Methotrexate vs. fumaric acid ...... y under daily life conditions.
@en
P2093
P2860
P304
P356
10.1111/J.1468-3083.2012.04596.X
P577
2012-06-02T00:00:00Z